Elucidating the Role of Trem2 in Lipid Metabolism and Neuroinflammation
CNS Neuroscience & Therapeutics · 2025-04 · 31 (4)
DOI: 10.1111/cns.70338 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 09.04.2025. Verfasst von Chenhui Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Northeast Agricultural University, Harbin, China. Hauptthemen laut MEDLINE: Lipid Metabolism, Membrane Glycoproteins, Receptors, Immunologic, Astrocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by cognitive impairment and neuroinflammation. Astrocytes play a key role in the neuroinflammatory environment of AD, especially through lipid metabolism regulation. However, the mechanisms by which astrocytes, particularly through the triggering receptor expressed on myeloid cells 2 (Trem2) receptor, contribute to lipid dysregulation and neuroinflammation in AD remain inadequately understood.
Methods
We employed an AD mouse model and integrated single‐cell RNA sequencing (scRNA‐seq), transcriptomics, and high‐throughput metabolomics to analyze lipid metabolism and inflammatory profiles in astrocytes. Differential gene expression was further validated with the GEO database, and in vitro and in vivo experiments were conducted to assess the impact of Trem2 modulation on astrocytic inflammation and lipid composition.
Results
Our findings demonstrate that Trem2 modulates lipid metabolism in astrocytes, affecting fatty acid and phospholipid pathways. In the AD model, Trem2 expression was suppressed, enhancing nuclear factor‐κB (NF‐κB) signaling and promoting the secretion of pro‐inflammatory factors such as tumor necrosis factor‐α (TNF‐α) and interleukin‐6 (IL‐6). Trem2 overexpression reduced astrocytic inflammation and altered lipid composition, attenuating neuroinflammation both in vitro and in vivo. These results underscore Trem2's regulatory role in lipid metabolism and its significant impact on neuroinflammation in AD.
Conclusions
This study identifies Trem2 as a pivotal regulator of astrocytic lipid metabolism and neuroinflammation in AD, providing potential molecular targets for early intervention and therapeutic strategies aimed at mitigating AD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
- Heilongjiang Key Laboratory of Laboratory Animals and Comparative Medicine, Harbin, China.
- Suzhou Frontage New Drug Development Co., Ltd., Suzhou, China.
ORCID-Profile: Chenhui Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhao, C., Qi, W., Lv, X., Gao, X., Liu, C., & Zheng, S. (2025). Elucidating the Role of Trem2 in Lipid Metabolism and Neuroinflammation. CNS Neuroscience & Therapeutics, 31(4). https://doi.org/10.1111/cns.70338
Vancouver
Zhao C, Qi W, Lv X, Gao X, Liu C, Zheng S. Elucidating the Role of Trem2 in Lipid Metabolism and Neuroinflammation. CNS Neuroscience & Therapeutics. 2025;31(4). doi:10.1111/cns.70338
BibTeX
@article{Zhao2025,
author = {Zhao, Chenhui and Qi, Wei and Lv, Xiaoping and Gao, Xueli and Liu, Chaonan and Zheng, Shimin},
title = {Elucidating the Role of Trem2 in Lipid Metabolism and Neuroinflammation},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {4},
doi = {10.1111/cns.70338}
}
EUVIMED